GROMACS Protein Analysisv1.0.0

A pharmaceutical company uses RMSD and RMSF analysis to evaluate the stability of a target protein under different drug candidate binding conditions. This helps identify the most promising compounds for lead optimization.

A biotech firm employs PCA and DCCM to study collective motions and correlated movements in enzyme mutants. This guides rational design of more efficient enzymes for industrial biocatalysis.

Research groups leverage gyrate and SASA analysis to monitor protein compactness and solvent accessibility during folding simulations, aiding in understanding folding pathways and misfolding diseases.

A structural biology lab uses FEL and PCA to map free energy landscapes and identify key conformational states of a membrane protein, providing insights into its functional mechanisms.

A cosmetics company applies RDCM and SASA to study how active ingredients interact with skin proteins, optimizing formulations for better penetration and efficacy.

Offer a cloud-based platform where researchers upload simulation data and access the GROMACS analysis pipeline remotely, paying a monthly or annual subscription fee.

Provide specialized MD analysis services to pharma and biotech companies lacking in-house expertise, charging per project or via retainer contracts.

License the analysis workflow as a standalone software package integrated with GROMACS and visualization tools, targeting institutional users with one-time or annual license fees.